Drug price inflation soars even as prices in the wider economy are stable.

The European Union has some 20 "biosimilar" generics on the market; the US has one.

Hedge funds are joining groups who want to lower prescription prices for consumers.

The company's CEO stepped down on Monday

A new report suggests drug makers are profiting from the waste.

Its Caremark unit covers some 25 million U.S. customers

The industry worries it's a step toward price controls.

More generics are needed to create competition — but can the FDA approve them fast enough?

It's not just a few bad players, as Congressional hearing puts drug costs in focus.